Applied Genetic Technologies Corp.
(NASDAQ : AGTC)

( )
AGTC After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.95%171.301.3%$495.18m
BIIBBiogen Inc.
0.91%235.041.3%$480.36m
CELGCelgene Corporation
0.11%96.361.3%$457.23m
GILDGilead Sciences, Inc.
-0.03%66.500.9%$434.72m
ILMNIllumina, Inc.
2.08%312.833.5%$317.70m
REGNRegeneron Pharmaceuticals, Inc.
3.27%320.092.6%$298.61m
AAgilent Technologies, Inc.
-0.50%67.981.6%$207.68m
VRTXVertex Pharmaceuticals Incorporated
1.92%172.371.9%$181.17m
EXASExact Sciences Corporation
-2.10%94.9125.3%$163.66m
ALXNAlexion Pharmaceuticals, Inc.
-0.97%127.552.0%$149.64m
BMRNBioMarin Pharmaceutical Inc.
0.25%87.694.3%$118.55m
SRPTSarepta Therapeutics, Inc.
0.36%121.6214.7%$112.14m
INCYIncyte Corporation
0.43%79.022.5%$105.72m
IONSIonis Pharmaceuticals, Inc.
-0.98%68.568.2%$98.74m
ALNYAlnylam Pharmaceuticals, Inc
-0.09%67.819.2%$94.94m

Company Profile

Applied Genetic Technologies Corp. engages in the development of gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.